Brief: Onward Medical Reaffirms Its Expected Cash Runway Through End Of 2024

ONWARD Medical

16/11/2023 06:37

Nov 16 (Reuters) - Onward Medical NV  ONWD.BR :
    * ONWARD EXPECTS TO CONTINUE STEADY AND CONSISTENT EXECUTION
OF
ITS STRATEGY IN THROUGH 2024
    * COMPANY PLANS TO SUBMIT A DE NOVO APPLICATION FOR FDA
CLEARANCE
OF THE ARC-EX SYSTEM IN 2024
    * COMPANY PLANS TO SUBMIT A DE NOVO APPLICATION FOR FDA
CLEARANCE
OF THE ARC-EX SYSTEM IN 2024
    * COMPANY REAFFIRMED ITS EXPECTED CASH RUNWAY THROUGH THE
END OF
2024 AND WILL LOOK FOR EFFICIENT WAYS TO FURTHER STRENGTHEN ITS
BALANCE SHEET IN THE COMING MONTHS
    * REPORTED CASH AND CASH EQUIVALENTS OF EUR 36.8 MILLION AS
OF
SEPTEMBER 30, 2023

Source text for Eikon:  ID:nGNELXQk5 
Further company coverage:  ONWD.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))